Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Regeneration and mitigation: an opinionated take on NEJM highlights for March 2017

  • NEJM
Gene therapy for sickle cell disease Typical diseases targeted by gene…

Read more

It’s in the blood: an opinionated take on NEJM highlights for February 2017

  • NEJM
A knock at the door of a monster franchise Adalimumab (Humira, Abbvie)…

Read more